Document Detail


Hypoxia due to shunts in pig lung treated with O2 and fluorocarbon-derived intravascular microbubbles.
MedLine Citation:
PMID:  20196682     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
RATIONALE: Earlier work has shown that experimental conditions calling for improved tissue oxygenation could be assisted by i.v. infusion of a dodecafluoropentane emulsion (DDFPe) forming oxygen-transporting microbubbles. OBJECTIVES: The present work investigated the effect of DDFPe on hypoxia due to experimental shunts in the pig lung. METHODS: Nineteen O(2) breathing, anesthetized pigs had glass beads administered into the trachea so as to significantly depress arterial oxygen tension (PaO(2)). PaO(2) was recorded for up to 12 hrs while 0.1 ml/kg DDFPe was administered 1-3 times. MAIN RESULTS: The animals were divided into two groups based on arterial oxygen saturation (SaO(2)) after shunt induction, combined with oxygen breathing: the "SaO(2) >90% group" (n=6) and the "SaO(2) <90% group" (n=13). In the "SaO(2) <90% group," the PaO(2) increased stepwise with each infusion from 56.6+/-2.9 to 88.6+/-14.6 mmHG (P<or=0.001); improvements lasted about 2 hrs after each infusion. Mixed venous oxygenation also increased with the infusions, e.g. (1(st) infusion) from a PvO(2) of 41.4+/-2.3 to 49.9+/-4.2 mmHg (P<or=0.05) and SvO(2) 58.0+/-2.9% (P<or=0.01), the venous changes supporting arterial oxygenation. At the same time, arterial CO(2) levels fell. Arterial O(2) and CO(2) levels were paralleled by similar changes in muscle tissue. Pulmonary arterial pressures did not indicate any pulmonary embolization by bubbles. Toxic effects of the treatment were not observed. CONCLUSION: These results suggest that, on condition of successful toxicity testing, intravascular administration of a DDFPe and oxygen breathing may be beneficial in severe right-to-left shunting in humans.
Authors:
Ingvald M Tyssebotn; Claes E G Lundgren; Albert J Olszowka; Guri W Bergoe
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Artificial cells, blood substitutes, and immobilization biotechnology     Volume:  38     ISSN:  1532-4184     ISO Abbreviation:  Artif Cells Blood Substit Immobil Biotechnol     Publication Date:  2010 Apr 
Date Detail:
Created Date:  2010-03-12     Completed Date:  2010-09-07     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9431307     Medline TA:  Artif Cells Blood Substit Immobil Biotechnol     Country:  England    
Other Details:
Languages:  eng     Pagination:  79-89     Citation Subset:  IM    
Affiliation:
Center for Research and Education in Special Environments and Department of Physiology and Biophysics, School of Medicine and Biomedical Sciences, State University of New York at Buffalo, Buffalo, NY 14214 , USA. ityssebo@buffalo.edu
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Anoxia / etiology,  therapy*
Arteriovenous Shunt, Surgical / adverse effects
Carbon Dioxide / metabolism
Disease Models, Animal
Fluorocarbons / administration & dosage*,  adverse effects
Hyperbaric Oxygenation*
Injections, Intravenous
Microbubbles / adverse effects,  utilization*
Oxygen / metabolism
Respiration / drug effects
Swine
Chemical
Reg. No./Substance:
0/Fluorocarbons; 124-38-9/Carbon Dioxide; 678-26-2/perfluoropentane; 7782-44-7/Oxygen

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Antigen-specific Immunoadsorption of Anti-acetylcholine Receptor Antibodies from Sera of Patients wi...
Next Document:  Structural and redox behavior of OxyVita, a zero-linked polymeric hemoglobin: comparison with natura...